Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7651698 | GALT PHARMS | Prolonged release bioadhesive therapeutic systems |
Sep, 2022
(4 months ago) | |
US6916485 | GALT PHARMS | Prolonged release bioadhesive therapeutic systems |
Sep, 2022
(4 months ago) | |
US8518442 | GALT PHARMS | Prolonged release bioadhesive therapeutic systems |
Sep, 2022
(4 months ago) |
Market Authorisation Date: 16 April, 2010
Treatment: Treatment of oropharyngeal candidiasis
Dosage: TABLET;BUCCAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic